To attend this session virtually, please click:

One tap mobile:

US: +13052241968,,93001454963# or +13092053325,,93001454963#

Meeting URL:

https://baystatehealth.zoom.us/j/93001454963?pwd=1e42iqdASnAxaP5Whm63o72hFJBBVp.1

Meeting ID:

930 0145 4963

Passcode:

036129

For questions, please contact Robert Ventulett via email at [email protected]. 

Objectives

After participating in this educational activity, attendees should be able to:
1| Identify the definition of hypertrophic cardiomyopathy (HCM) and the pathophysiology.
2| Discuss the significance of HCM in current clinical practice.
3| Recognize clinical signs and symptoms during history, physical and routine cardiac testing typical of HCM.
4| Identify testing required for diagnosis of HCM.
5| Implement most appropriate treatment for patients diagnosed with HCM.
6| Identify how/when to refer to HCM clinic within Advanced Heart Failure program at Baystate Health.

Presenter(s): 

Francis Sabas, DNP, AG-ACNP
Cardiac Services, Baystate Health

Shawn Selby, DNP, AG-ACNP
Cardiac Services, Baystate Health

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?

Francis Sabas, DNP 

 

Speaker/Author

 

No relevant relationships with ineligible companies to disclose

 

No

 

Shawn Selby, DNPSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

 

Session date: 
06/02/2026 - 6:30pm to 7:30pm EDT
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.